Lupin Limited Financial Ratios
LUPIN · Healthcare · Current price ₹1,961.6
P/E ratio
16.8x
P/B ratio
4.2x
ROE
23.8%
ROCE
25.1%
Debt / Equity
0.29
Dividend yield
0.9%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 16.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 4.2x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 23.8% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 25.1% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.29 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Lupin Limited's latest numbers.
Lupin Limited profitability
Lupin Limited generates a return on equity of 23.8% and a return on capital employed of 25.1%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.29 and a P/E of 16.8x, Lupin Limited is conservatively financed. Our overall business-quality score for the company is 7.5 / 10.
Understand the ratios
More on Lupin Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.